Zimmer Biomet (ZBH) financials
Zimmer Biomet revenue and earnings by year
Zimmer Biomet's revenue was $8.23 billion in the fiscal year to December 31, 2025, up 7.2% from the year before. Net income was $705 million, 8.6% of revenue. Since the fiscal year to December 31, 2016, revenue has grown 0.8% a year on average.
Fiscal years, each labelled by the calendar year it ended in.
Income statement, the last 10 fiscal years
| Fiscal year to | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 8.23 | 7.68 | 7.39 | 6.94 | 6.83 | 6.13 | 7.98 | 7.93 | 7.80 | 7.67 |
| Revenue growth | 7.2% | 3.8% | 6.5% | 1.6% | 11.4% | -23.2% | 0.6% | 1.7% | 1.8% | — |
| Gross profit | 5.74 | 5.49 | 5.31 | 4.92 | 4.87 | 4.30 | 5.73 | 5.66 | 5.67 | 5.29 |
| Gross margin | 69.7% | 71.5% | 71.8% | 70.9% | 71.3% | 70.2% | 71.8% | 71.4% | 72.7% | 68.9% |
| Operating income | 1.10 | 1.29 | 1.28 | 0.70 | 0.86 | 0.08 | 1.14 | 0.03 | 0.80 | 0.82 |
| Operating margin | 13.3% | 16.7% | 17.3% | 10.0% | 12.6% | 1.4% | 14.3% | 0.4% | 10.2% | 10.7% |
| Net income | 0.71 | 0.90 | 1.02 | 0.23 | 0.40 | -0.14 | 1.13 | -0.38 | 1.81 | 0.31 |
| Net margin | 8.6% | 11.8% | 13.8% | 3.3% | 5.9% | -2.3% | 14.2% | -4.8% | 23.2% | 4.0% |
| Diluted EPS | $3.55 | $4.43 | $4.88 | $1.10 | $1.85 | -$0.69 | $5.31 | -$1.83 | $8.62 | $1.46 |
| Free cash flow | 1.17 | 1.06 | 0.98 | -0.52 | 1.07 | 0.83 | 0.87 | 1.31 | 1.09 | 1.10 |
Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open ZBH in Markets.
How Zimmer Biomet makes money
Revenue by segment in the quarter to June 30, 2026, as the company reports it.
| Segment | Revenue | Share |
|---|---|---|
| Knees | $829M | 38.1% |
| SET | $586M | 26.9% |
| Hips | $563M | 25.8% |
| Technology & Data Bone Cement & Surgical | $199M | 9.2% |
See also: ZBH valuation and P/E history · ZBH returns
No forecast, no recommendation. This page describes Zimmer Biomet from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.